Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29447338 | 1.00 | ALDH1A1 (0.39) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL29695262 | 0.98 | ALDH1A1 (0.38) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| Potassium SCHEMBL29695394 | 0.96 | WDR5 (0.37) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL8020132 | 0.91 | CYP2A6 (0.41) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL8056031 | 0.91 | CES1 (0.36) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL8056374 | 0.89 | MAPT (0.33) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL9014995 | 0.89 | WDR5 (0.33) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL5828913 | 0.89 | DNMT1 (0.37) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL8537985 | 0.89 | DNMT1 (0.37) | ALDH1A1HSD17B10TDP1CYP2A6TSHR | |
| SCHEMBL7776442 | 0.87 | ALOX5 (0.36) | ALDH1A1TDP1TSHRMAPTHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3104970-B1 | METHOD FOR REGENERATING SPENT HYDROFORMYLATION CATALYSTS | OXEA GMBH (DE) | 2018-03-28 | — | — | EP | claimed |
| US-8927776-B2 | Method for hydroformylation of unsaturated compounds | EVONIK DEGUSSA GMBH (DE) | 2015-01-06 | — | — | US | claimed |
| US-20140024860-A1 | METHOD FOR HYDROFORMYLATION OF UNSATURATED COMPOUNDS | EVONIK OXENO GMBH (DE) | 2014-01-23 | — | — | US | claimed |
| EP-0673944-B1 | Process for preparing 2,2'-bis(diphenyl-phosphinylmethyl)-1,1'binaphtyl and novel compounds belonging to this group of substances | CELANESE CHEM EUROPE GMBH (DE) | 2001-08-16 | — | — | EP | claimed |
| US-6051743-A | Process for the preparation of predominantly unbranched higher primary alcohols | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-04-18 | — | — | US | claimed |
| EP-0571819-B1 | Sulfonated 2,2'-bis(diphenylphosphinomethyl)-1,1'-binaphthalenes, process for their preparation and their use in a process for the hydroformylation of olefinic unsaturated compounds | CELANESE GMBH (DE) | 1998-11-11 | — | — | EP | claimed |
| EP-0446301-B1 | PREPARATION OF BIARYL COMPOUNDS | EASTMAN CHEM CO (US) | 1994-11-23 | — | — | EP | claimed |
| EP-0602442-A2 | Method for the production of higher primary alcohols, predominantly unbranched | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-22 | — | — | EP | claimed |
| EP-0571819-A1 | Sulfonated 2,2'-bis(diphenylphosphinomethyl)-1,1'binaphthalenes, process for their preparation and their use in a process for the hydroformylation of olefinic unsaturated compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-12-01 | — | — | EP | claimed |
| US-5061669-A | Catalyst comprising anhydrous nickel compound, bidentate phosphorus-containing ligand, reducing metal | EASTMAN KODAK COMPANY (US) | 1991-10-29 | — | — | US | claimed |
| EP-0446301-A1 | PREPARATION OF BIARYL COMPOUNDS. | EASTMAN KODAK CO (US) | 1991-09-18 | — | — | EP | claimed |
| EP-0376856-A1 | Preparation of biaryl compounds | EASTMAN KODAK COMPANY (US) | 1990-07-04 | — | — | EP | claimed |
| WO-1990006295-A1 | PREPARATION OF BIARYL COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1990-06-14 | — | — | WO | claimed |
| US-4916227-A | From aromatic halide using coordinating catalyst containing nickel, phosphorus containing ligand, and reducing metal | EASTMAN KODAK COMPANY (US) | 1990-04-10 | — | — | US | claimed |
| JP-7252279-A | — | — | None | — | — | JP | disclosed |
| JP-6145181-A | — | — | None | — | — | JP | disclosed |
| US-12630572-B2 | Method for preparing sulfonated arylphosphine | Hanwha Solutions Corporation (KR) | 2026-05-19 | — | — | US | disclosed |
| EP-0050196-B1 | PROCESS FOR THE PREPARATION OF PEPTIDES | Degussa Aktiengesellschaft (DE) | 1983-11-23 | — | — | EP | disclosed |
| EP-0050196-A1 | Process for the preparation of peptides | Degussa Aktiengesellschaft (DE) | 1982-04-28 | — | — | EP | disclosed |
| US-4204997-A | Asymmetric amination of 1,3-dienes | MONSANTO COMPANY (US) | 1980-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630572-B2 | Method for preparing sulfonated arylphosphine | TST, TPR, ALK | ALDH1A1 706/4885HSD17B10 1621/4885TDP1 2543/4885 |
| US-20140024860-A1 | METHOD FOR HYDROFORMYLATION OF UNSATURATED COMPOUNDS | HRH4, HRH3, HRH2 | ALDH1A1 1480/4885HSD17B10 385/4885TDP1 4406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.